Literature DB >> 24079843

The prevalence and genetics of Parkinson's disease in sub-Saharan Africans.

Janine Blanckenberg1, Soraya Bardien, Brigitte Glanzmann, Njideka U Okubadejo, Jonathan A Carr.   

Abstract

Parkinson's disease (PD) is under-studied in Black Sub-Saharan African (SSA) populations. To date, there have been only six prevalence and no incidence studies. The crude prevalence of PD in SSA varies from 7 to 20 per 100,000, which is appreciably lower than in Caucasian populations. There are a limited number of published studies (nine) on the genetic factors associated with PD in SSA populations. Mutations have been reported in the parkin gene, and are restricted to only three patients (two Black South Africans and one Zambian). No mutations have been identified in the LRRK2, SNCA, PINK, or DJ-1 genes. Given the unique ancestry of SSA populations, their inclusion in genetic studies may provide a substantial contribution to the identification of novel genetic factors and genetic-environmental interactions underlying this disorder. More initiatives are needed to drive further research on PD in these populations and to facilitate collaborative projects across Africa.
© 2013.

Entities:  

Keywords:  Epidemiology; Etiology; Genetic studies; Parkinson's disease; Prevalence; Sub-Saharan Africa

Mesh:

Substances:

Year:  2013        PMID: 24079843     DOI: 10.1016/j.jns.2013.09.010

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

Review 1.  Parkinson's disease in Nigeria: A review of published studies and recommendations for future research.

Authors:  Oluwafemi G Oluwole; Helena Kuivaniemi; Jonathan A Carr; Owen A Ross; Matthew O B Olaogun; Soraya Bardien; Morenikeji A Komolafe
Journal:  Parkinsonism Relat Disord       Date:  2018-12-08       Impact factor: 4.891

Review 2.  Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling.

Authors:  Rainer Knörle
Journal:  Neurotox Res       Date:  2017-09-06       Impact factor: 3.911

3.  Neurexin 2 p.G849D variant, implicated in Parkinson's disease, increases reactive oxygen species, and reduces cell viability and mitochondrial membrane potential in SH-SY5Y cells.

Authors:  Katelyn Cuttler; Dalene de Swardt; Lize Engelbrecht; Jurgen Kriel; Ruben Cloete; Soraya Bardien
Journal:  J Neural Transm (Vienna)       Date:  2022-10-15       Impact factor: 3.850

Review 4.  Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Tolulope Oyeniyi; Bruce Ovbiagele; Donna K Arnett; Hemant K Tiwari; Richard Walker; Adesola Ogunniyi; Raj N Kalaria
Journal:  J Neurol Sci       Date:  2016-05-06       Impact factor: 3.181

5.  Utility of 18F FDG-PET in Parkinsonism in an African population.

Authors:  Ferzana Hassan Amod; Ahmed Iqbal Bhigjee; Nozipho Nyakale
Journal:  eNeurologicalSci       Date:  2022-03-31

Review 6.  Neuroscience-related research in Ghana: a systematic evaluation of direction and capacity.

Authors:  Emmanuel Quansah; Thomas K Karikari
Journal:  Metab Brain Dis       Date:  2015-09-07       Impact factor: 3.584

7.  Knowledge and Attitudes of Parkinson's Disease in Rural and Urban Mukono District, Uganda: A Cross-Sectional, Community-Based Study.

Authors:  Mark Kaddumukasa; Angelina Kakooza; Martin N Kaddumukasa; Edward Ddumba; Levi Mugenyi; Martha Sajatovic; Elly Katabira
Journal:  Parkinsons Dis       Date:  2015-11-25

8.  Alpha-synuclein mRNA isoform formation and translation affected by polymorphism in the human SNCA 3'UTR.

Authors:  Elizabeth S Barrie; Sung-Ha Lee; John T Frater; Maria Kataki; Douglas W Scharre; Wolfgang Sadee
Journal:  Mol Genet Genomic Med       Date:  2018-05-06       Impact factor: 2.183

Review 9.  Neurogenomics: An opportunity to integrate neuroscience, genomics and bioinformatics research in Africa.

Authors:  Thomas K Karikari; Jelena Aleksic
Journal:  Appl Transl Genom       Date:  2015-07-22

Review 10.  Parkinson's Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care.

Authors:  Uduak Williams; Oliver Bandmann; Richard Walker
Journal:  J Mov Disord       Date:  2018-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.